Plain Language Summaries

Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience

Animated Videos

Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a plain language summary of the ARASENS trial

The ARASENS trial looked at the role of darolutamide in the treatment of patients with a type of prostate cancer called metastatic, hormone-sensitive prostate cancer. This plain language summary of publication, published in Future Oncology, provides an overview of this trial written in non-technical language. The summary includes commentary from patients and a caregiver and can help a wider audience, including patient advocates and healthcare professionals, understand the findings from this trial.

Learn more about the ARASENS trial originally published in the New England Journal of Medicine in this animated video that provides an overview of the plain language summary of publication.

Watch the video below or read the fully plain language summary here.

Vosoritide treatment accelerates bone growth in children with achondroplasia (Animated video)

Two recent studies have been carried out looking at vosoritide as a treatment for children with achondroplasia. A free-to-read plain language summary, written in easy-to-understand language, has recently been published in the peer-reviewed journal Future Rare Diseases to help a lay audiences, including caregivers and parents of children with achondroplasia, understand the results of these two studies. This video provides a summary of this article.

Watch the video below or read the article here.

A plain language summary of the EXPLORER-HCM study: mavacamten for obstructive hypertrophic cardiomyopathy (Animated video)

Future Cardiology has recently published it’s first standalone plain language summary looking at the results of the EXPLORER-HCM trial. The authors were keen to help patients learn about the potential role for mavacamten as a treatment for hypertrophic cardiomyopathy and chose to accompany their article with this animated video.

Learn more about the video and article ‘A plain language summary of the EXPLORER-HCM study: mavacamten for obstructive hypertrophic cardiomyopathy’ here.

Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial (Animated video)

A plain language summary of the ARAMIS study, that looked looked at the role of darolutamide in the treatment of patients with nonmetastatic, castration-resistant prostate cancer, has recently been published in Future Oncology. This Animated Video provides an overview of the plain language summary.

Read the full article ‘Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial’ here.